Editorial: Update on Anti-EGFR therapy

Editorial: Update on Anti-EGFR therapy

Saved in:

書目詳細資料
Main Authors:	Daniel Chua, Peter Fasching, Brigette Ma, Sumitra Thongprasert, Lori Wirth
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=70349237032&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49300
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Editorial: Update on Anti-EGFR therapy
由: Daniel Chua, et al.
出版: (2018)

Editorial: Inflammatory muscle diseases: an update
由: Tanboon J.
出版: (2023)

Response Evaluation on Single Common and Uncommon EGFR Mutation on First-Generation EGFR-TKI Therapy in NSCLC Patients
由: Rena Arusita Maranatha, et al.
出版: (2021)

In-vitro studies of anti-egfr tyrosine kinase activity of thai nutraceutical plants
由: Suwanna Semsri, et al.
出版: (2020)

Combined use of anti-VEGF and Anti-EGFR monoclonal antibodies with Photodynamic therapy suppresses tumor growth in an in vivo tumor model
由: Bhuvaneswari, R, et al.
出版: (2020)

Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
由: Chalyut Charoentum, et al.
出版: (2018)

The Singapore Journal of Tropical Geography in transition: An editorial update
由: Bunnell, T., et al.
出版: (2014)

Growth hormone therapy update in Thailand
由: Kitti A. Angsusingha, et al.
出版: (2018)

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
由: Yuankai Shi, et al.
出版: (2018)

Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy
由: Sahrun, -, et al.
出版: (2019)

Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk
由: Ung, C.Y., et al.
出版: (2014)

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer
由: Saifon W.
出版: (2023)

Update On The Treatment Of type 2 Diabetes Mellitus: Focus On Oral Therapy
由: Agung Pranoto, NIDN. 0004015605
出版: (2018)

Update on influenza anti-virals
由: Tambyah, P.A.
出版: (2011)

Clinical Benefit of EGFR-TKI in Management of NSCLC
由: Siprianus Ugroseno Yudho Bintoro
出版: (2017)

Crizotinib treatment for advanced non-small-cell lung cancer patients: a budget impact analysis based in Thailand
由: Sumitra Thongprasert, et al.
出版: (2018)

Editorial comment
由: Dr B Lojanapiwat
出版: (2018)

Editorial comment
由: Dr B Lojanapiwat
出版: (2018)

Editorial comment
由: Bannakij Lojanapiwat
出版: (2018)

Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response
由: Bhuvaneswari R., et al.
出版: (2018)

Role of BIM deletion polymorphism and BIM expression as predictive biomarkers to maximize the benefit of EGFR-TKI treatment in EGFR-Positive NSCLC
由: Pimpin Incharoen, et al.
出版: (2020)

Editorial
由: Chua, T.-S.
出版: (2014)

Updates on therapies for Duchenne and Becker muscular dystrophy
由: Tay, S.
出版: (2016)

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival
由: Chee Khoon Lee, et al.
出版: (2018)

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
由: Suresh S. Ramalingam, et al.
出版: (2020)

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
由: Suresh S. Ramalingam, et al.
出版: (2020)

Editorial: Antifungal drug discovery: New theories and new therapies
由: Seneviratne, C.J, et al.
出版: (2020)

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis
由: Chee Khoon Lee, et al.
出版: (2018)

Correlation Between VEGF and EGFR Expression in Urothelial Carcinoma of Bladder
由: Anny Setijo Rahaju, Anny, et al.
出版: (2021)

P53: Updates on mechanisms, biology and therapy (I)
由: Lane, D.P., et al.
出版: (2021)

P53: Updates on mechanisms, biology and therapy (II)
由: Verma, C.S.
出版: (2021)

Update on dermatomyositis
由: Tanboon J.
出版: (2023)

Correlation Between VEGF and EGFR Expression in Urothelial Carcinoma of Bladder
由: Anny Setijo Rahaju, Anny, et al.

Correlation Between VEGF and EGFR Expression in Urothelial Carcinoma of Bladder
由: Anny Setijo Rahaju, Anny, et al.

Correlation Between VEGF and EGFR Expression in Urothelial Carcinoma of Bladder
由: Anny Setijo Rahaju, -, et al.

An evidence-based update on nonsteroidal anti-inflammatory drugs
由: Ong, C.K.S., et al.
出版: (2013)

The adenomatoid odontogenic tumour: an update of selected issues
由: Hans Peter Philipsen, et al.
出版: (2018)

Lung cancer in Maharaj Nakorn Chiang Mai Hospital: Comparison of the clinical manifestations between the young and old age groups
由: Athavudh Deesomchok, et al.
出版: (2018)

A current update in COVID-19 associated acute respiratory distress syndrome: Focus on mesenchymal stem cell therapy
由: David Nugraha, -, et al.
出版: (2020)

PERBANDINGAN RESPONS KEMOTERAPI DAN EFEK SAMPING PENGGUNAAN PLATINUM DOUBLET KOMBINASI EGFR TKI DENGAN PLATINUM DOUBLET TUNGGAL PADA PENDERITA NSCLC MUTASI GEN EGFR PROGRESSIVE DISEASE
由: Edward Pandu Wiriansya
出版: (2017)